Skip to Content
MilliporeSigma

Key Documents

View All Documentation

Skip To

A56655

Sigma-Aldrich

4-Amino-3-hydroxybutyric acid

98%

Synonym(s):

DL-γ-Amino-β-hydroxybutyric acid

Sign Into View Organizational & Contract Pricing

About This Item

Linear Formula:
H2NCH2CH(OH)CH2CO2H
CAS Number:
924-49-2
Molecular Weight:
119.12
EC Number:
213-106-9
MDL number:
MFCD00008141
UNSPSC Code:
12352106
PubChem Substance ID:
24891011
NACRES:
NA.22
Pricing and availability is not currently available. Contact Technical Service
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

100

Assay

98%

form

powder or crystals

reaction suitability

reaction type: solution phase peptide synthesis

color

white to yellow

mp

223 °C (dec.) (lit.)

application(s)

peptide synthesis

SMILES string

NCC(O)CC(O)=O

InChI

1S/C4H9NO3/c5-2-3(6)1-4(7)8/h3,6H,1-2,5H2,(H,7,8)

InChI key

YQGDEPYYFWUPGO-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
H40215492564340
4-Amino-3-hydroxybutyric acid 98%

A56655

4-Amino-3-hydroxybutyric acid

D-Homoserine

H4021

D-Homoserine

(S)-3-Hydroxybutyric acid ≥97.0%

54925

(S)-3-Hydroxybutyric acid

DL-Methionine ≥99.0% (NT)

64340

DL-Methionine

form

powder or crystals

form

powder

form

powder or crystals

form

powder or crystals

assay

98%

assay

≥98% (TLC)

assay

≥97.0%

assay

≥99.0% (NT)

Quality Level

100

Quality Level

200

Quality Level

100

Quality Level

200

mp

223 °C (dec.) (lit.)

mp

205 °C (dec.) (lit.)

mp

45-50 °C

mp

280 °C (dec.) (lit.)

color

white to yellow

color

white

color

-

color

white

reaction suitability

reaction type: solution phase peptide synthesis

reaction suitability

-

reaction suitability

-

reaction suitability

-

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves
  • Specification Sheet

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    MKCN3417
    MKCG0321
    MKBZ0060V
    MKBZ0059V
    MKBP5875V

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    G B Melis et al.
    Journal of endocrinological investigation, 5(2), 101-106 (1982-03-01)
    The effect of gamma-amino beta-hydroxy butyric acid (GABOB) infusion on GH secretion has been investigated in 3 groups of 6 normal women. Different doses (100 mg/min, 20 mg/min, 3.5 mg/min) of GABOB diluted with normal saline solution were infused iv
    Stereoselective analysis of racemic psychotropic compounds by HPLC on chiral stationary phase.
    D F Smith et al.
    Psychopharmacology, 89(3), 392-393 (1986-01-01)
    G Bonardi et al.
    Arzneimittel-Forschung, 31(11), 1910-1913 (1981-01-01)
    1. Serum levels of DL-gamma-amino-beta-hydroxybutyric acid-1-14C (DL-GABOB-1-14C) in the rat (50 mg/kg) were quite similar after single i.v. and p.o. doses. Also the disappearance from the serum was similar with both administration routes. Within 6 days after p.o. treatment with
    Elzbieta J Tadeusiak
    Bioorganic chemistry, 32(6), 473-482 (2004-11-09)
    The involvement of carnitine and gamma-amino-beta-hydroxybutyric acid in the biology of mammalian cells, the physiology of the human body, and some important aspects of medicinal treatment has induced many research groups to develop their pharmacologically potent analogues. Among them are
    M A Enero et al.
    Clinical and experimental hypertension. Part A, Theory and practice, 10 Suppl 1, 331-337 (1988-01-01)
    The cardiovascular effects of i.v. gamma-amino-beta-hydroxybutyric acid (GABOB) were investigated in rats anaesthetized with urethane. GABOB produced a dose-dependent hypotensive response. Treatment with GABA-A receptor antagonists prevented the GABOB response while the GABA stimulation by diazepam enhanced this response. The
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service